My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2023-140
CBCC
>
Official Documents
>
2020's
>
2023
>
2023-140
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/4/2023 12:08:17 PM
Creation date
8/4/2023 12:06:37 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Agreement
Approved Date
07/11/2023
Control Number
2023-140
Agenda Item Number
8.T.
Entity Name
RxBenefits. Inc. f/k/a Prescription Benefits, Inc
Subject
Addendum to Administrative Service Agreement reflecting improved pricing
and updates effective January1, 2023
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
23
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
DocuSign Envelope ID: 5332467E-CBEF-4C5D-8BOE-61E38OBDA11B <br />DocuSign Envelope ID: 151ECOCF-B55C-414F-9455-72004347A310 <br />(1/2023 Version) <br />This component requires that Client elect a standard Utilization Management Programs promoted by <br />Administrator. NOTE: Client must have HDCR component in place to elect UM. The following may <br />apply: <br />o Review turnaround time is dependent on prescriber activity and whether additional information <br />is required. If additional information is required, the reviewer will attempt to contact physician <br />at least once daily for three days; direct contact with the prescriber will discontinue after the <br />third day. The majority of reviews are completed with a disposition within 24 to 72 hours.; <br />o Following a clinical review, one of four actions will occur: (i) the medication is approved, (ii) <br />the medication claim is denied, (iii) the prescriber may decide to withdraw and prescribe a <br />different medication, or (iv) the reviewer can dismiss the claim due to lack of communication <br />from the prescriber, or <br />o If denied, an appeal process is available. <br />2.3 Protect Proeram Guarantee <br />• General: The Administrator clinical programs elected by Client shall be collectively referred <br />to as the "Protect Solutions" for purposes of this Exhibit A. The fees associated with the Protect <br />Solutions which are invoiced to the client shall be referred to herein as the "Protect Fees'. <br />• Protect ROI Guarantee: Administrator guarantees that Client will generate savings from the <br />Protect Solutions ("Protect Savings") that are equal to or greater than the Protect Fees paid by <br />Client during the given Contract Year (the "Protect ROI Guarantee"). To the extent that the <br />Protect Fees exceed the Protect Savings in a given Contract Year, Administrator will pay Client <br />an amount equal to the difference between the Protect Fees and the Protect Savings (the "Protect <br />Guarantee Payment). <br />• Conditions. <br />o Eligibility. To be eligible for the Protect ROI Guarantee, Client must be on one of <br />Administrator's four Protect Program packages: <br />o Advanced; <br />o Intermediate; <br />o Basic; or <br />o Custom UM. <br />In all instances, Administrator's LCV and HDCR programs must be elected. <br />o Protect Savings Validation: Protect Savings are calculated using a proprietary <br />methodology developed by Administrator that analyzes rejected Claims and the paid <br />alternatives to calculate definitive actual -dollar savings realized as a result of the <br />Protect Solutions. Protect Savings generated by the PA and appeals process are based <br />on the AWP contracted discount for the specific drug involved in a Claim. Protect <br />Savings generated by the HDCR process are based on the net cost after actual discount. <br />Administrator may use information from PBM in its calculation of Protect Savings <br />(e.g., AWP, gross cost, plan cost, member cost, rejected Claims data). Generic product <br />identifier (GPI) and national drug code (NDC) data will be retrieved from Medi -Span. <br />o Within one hundred and twenty (120) days after the end of each Contract year, <br />Administrator shall report to Client performance for the Protect ROI Guarantee. If <br />Protect Savings exceeds Protect Fees during a Contract Year, no payment shall be <br />made by Administrator to Client. If Protect Fees exceed Protect Savings, amounts due <br />resulting from an Administrator failure to meet the Protect ROI Guarantee, shall be <br />calculated and paid to Client within thirty (30) days following Administrator's <br />reconciliation report. <br />o The Protect Guarantee Payment, if any, shall be issued as a credit to Client's account. <br />Client must have the Protect Solutions in place for the entirety of the Agreement Term <br />9 <br />NOT FOR DISTRIBUTION. THE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL, PROPRIETARY <br />AND CONSTITUTES TRADE SECRETS OF ESI AND RXBENEFITS <br />
The URL can be used to link to this page
Your browser does not support the video tag.